Scarica l'app Stockscreener
4.68
1.52%
0.07
Pre-mercato:
4.67
-0.010
-0.21%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MYGN Giù?
Forum
Previsione
Frazionamento azionario
Myriad Genetics Inc Borsa (MYGN) Ultime notizie
Myriad (MYGN) Up 4.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance UK
Myriad Genetics launches Prequel Prenatal Screen using AMPLIFY technology for early chromosomal risk detection - Traders Union
Myriad Genetics (MYGN) CSO has shares withheld to cover RSU taxes - Stock Titan
Myriad Genetics (MYGN) COO has 2,055 shares withheld to cover taxes - Stock Titan
Myriad Genetics (MYGN) CFO uses 549 shares for RSU tax withholding - Stock Titan
MYGN Stock Price, Quote & Chart | MYRIAD GENETICS INC (NASDAQ:MYGN) - ChartMill
Myriad Genetics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Myriad Genetics, Inc.(NasdaqGS: MYGN) dropped from S&P 600 - marketscreener.com
Myriad Genetics, Inc.(NasdaqGS: MYGN) dropped from S&P Composite 1500 - marketscreener.com
Myriad Genetics, Inc.(NasdaqGS: MYGN) dropped from S&P 600 Health Care - marketscreener.com
Myriad Genetics, Inc.(NasdaqGS: MYGN) dropped from S&P 1000 - marketscreener.com
Gene Patent Showdown For Myriad Comes to a Head - Yahoo
MYGN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Why Myriad Genetics (MYGN) is a Top Growth Stock for the Long-Term - Yahoo Finance
Prequel Prenatal Screen enables providers to act on uncertain results, Myriad Genetics asserts - Traders Union
Why Myriad Genetics (MYGN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Myriad Genetics (MYGN) Q4 earnings and revenues surpass estimates - MSN
Myriad Genetics receives FDA approval for ovarian cancer test By Investing.com - Investing.com South Africa
FDA Approves Myriad Genetics' MyChoice CDx Test for Advanced Ova - GuruFocus
Myriad Genetics receives FDA approval for ovarian cancer test - Investing.com
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer - The Manila Times
Portfolio Update: Can Myriad Genetics Inc maintain its current growth rate2026 Trading Volume Trends & Community Driven Trade Alerts - baoquankhu1.vn
Myriad Genetics (MYGN) CTO has shares withheld to cover taxes - Stock Titan
Myriad Genetics (MYGN) CFO granted 206,186 RSUs, 4,752 shares withheld - Stock Titan
Myriad Genetics (MYGN) grants 173196 RSUs, withholds 14683 shares for tax - Stock Titan
Myriad Genetics (MYGN) CSO gets 173,196 RSUs, withholds 37,799 shares - Stock Titan
Myriad Genetics (MYGN) CLO granted 195,876 RSUs and has shares withheld - Stock Titan
Myriad Genetics (MYGN) Chief Commercial Officer granted 226,804 RSUs - Stock Titan
Myriad Genetics (MYGN) COO receives RSU grant, shares withheld for tax - Stock Titan
Myriad Genetics (MYGN) CEO gets 618,557 RSUs, 47,120 shares withheld - Stock Titan
Myriad Genetics Inc Stock (ISIN: US62855J1043) Eyes Precision Medicine Growth Amid Margin Expansion - AD HOC NEWS
Myriad Genetics, Inc. $MYGN Shares Sold by Anson Funds Management LP - MarketBeat
Market Review: Is now the right time to enter Myriad Genetics Inc2026 Selloffs & Accurate Intraday Trading Signals - baoquankhu1.vn
3 Reasons to Sell MYGN and 1 Stock to Buy Instead - Yahoo Finance
Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc - Yahoo Finance
Myriad Genetics at Leerink Conference: Strategic Moves in Cancer Care By Investing.com - Investing.com Canada
Myriad Genetics (MYGN) Shares Skyrocket, What You Need To Know - Finviz
Raha, Myriad Genetics CEO, buys $199k in shares By Investing.com - Investing.com South Africa
Insider Buying: Samraat Raha Acquires 40,000 Shares of Myriad Ge - GuruFocus
Myriad Genetics (NASDAQ:MYGN) CEO Purchases $200,000.00 in Stock - MarketBeat
Raha, Myriad Genetics CEO, buys $199k in shares - Investing.com Nigeria
Trading Systems Reacting to (MYGN) Volatility - Stock Traders Daily
Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2025 Earnings Call Transcript - MSN
Myriad Genetics Q4 2025 earnings preview - MSN
Trading Recap: Whats next for Myriad Genetics Inc stockBreakout Watch & Consistent Return Strategy Ideas - baoquankhu1.vn
Take Profit: What hedge funds are buying Myriad Genetics IncMarket Sentiment Review & Weekly High Momentum Picks - baoquankhu1.vn
Royce & Associates LP Makes New $4.84 Million Investment in Myriad Genetics, Inc. $MYGN - MarketBeat
Myriad Genetics, Inc. (MYGN) Competitors - Meyka
Myriad Genetics (NASDAQ: MYGN) files $200M shelf for equity and debt sales - Stock Titan
Myriad Genetics Stock Up on New Breast Cancer MRD Test Launch | 2026News and Statistics - IndexBox
MYGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Myriad Genetics (MYGN) Stock Trades Up, Here Is Why - Finviz
Myriad Commercially Launches Precise MRD with Select Community Oncologists - Bitget
Myriad Genetics (MYGN) CPO has shares withheld to cover taxes - Stock Titan
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Myriad Genetics (NASDAQ:MYGN) Stock Rating Upgraded by Zacks Research - MarketBeat
0.19%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):